Used in pharmaceutical synthesis as an intermediate for nucleoside analogs, particularly in the development of antiviral and anticancer agents. Its structure allows incorporation into modified nucleotides, enhancing stability and bioavailability of active compounds. Also employed in research settings for probing enzyme mechanisms involving purine metabolism. Suitable for solid-phase oligonucleotide synthesis when modified appropriately.